IDEAYA Biosciences, Inc. (IDYA)
36.11
+0.05
(+0.14%)
USD |
NASDAQ |
Oct 09, 16:00
35.60
-0.51
(-1.41%)
After-Hours: 20:00
IDEAYA Biosciences Cash from Investing (Quarterly) : -155.93M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -155.93M |
| March 31, 2026 | 118.95M |
| December 31, 2025 | -97.53M |
| September 30, 2025 | 41.77M |
| June 30, 2025 | 45.92M |
| March 31, 2025 | 79.82M |
| December 31, 2024 | -197.11M |
| September 30, 2024 | -20.04M |
| June 30, 2024 | 68.56M |
| March 31, 2024 | -353.97M |
| December 31, 2023 | -111.94M |
| September 30, 2023 | 51.35M |
| June 30, 2023 | -121.38M |
| March 31, 2023 | 23.52M |
| December 31, 2022 | -10.28M |
| September 30, 2022 | -18.68M |
| June 30, 2022 | 13.32M |
| Date | Value |
|---|---|
| March 31, 2022 | -17.76M |
| December 31, 2021 | -0.413M |
| September 30, 2021 | -56.31M |
| June 30, 2021 | -49.38M |
| March 31, 2021 | 36.44M |
| December 31, 2020 | -4.554M |
| September 30, 2020 | -183.58M |
| June 30, 2020 | 30.99M |
| March 31, 2020 | 10.91M |
| December 31, 2019 | 3.887M |
| September 30, 2019 | -38.44M |
| June 30, 2019 | 11.41M |
| March 31, 2019 | 25.41M |
| December 31, 2018 | 6.576M |
| September 30, 2018 | 5.261M |
| June 30, 2018 | -14.52M |
| March 31, 2018 | -60.49M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| Xencor, Inc. | 85.12M |
| BioMarin Pharmaceutical, Inc. | -5.102B |
| MediciNova, Inc. | 0.00 |
| Viking Therapeutics, Inc. | 109.43M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -88.21M |
| Cash from Financing (Quarterly) | 359.21M |
| Free Cash Flow | -113.87M |
| Free Cash Flow Per Share (Quarterly) | -0.9676 |
| Free Cash Flow to Equity (Quarterly) | -89.78M |
| Free Cash Flow to Firm (Quarterly) | -89.08M |
| Free Cash Flow Yield | -3.51% |